BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 220573)

  • 1. Endometrial pathology and estrogens.
    Rosenwaks Z; Wentz AC; Jones GS; Urban MD; Lee PA; Migeon CJ; Parmley TH; Woodruff JD
    Obstet Gynecol; 1979 Apr; 53(4):403-10. PubMed ID: 220573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial response to estrogen and progesterone therapy in patients with gonadal dysgenesis.
    Benjamin I; Block RE
    Obstet Gynecol; 1977 Aug; 50(2):136-8. PubMed ID: 876552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women.
    Magos AL; Brincat M; Studd JW; Wardle P; Schlesinger P; O'Dowd T
    Obstet Gynecol; 1985 Apr; 65(4):496-9. PubMed ID: 2984616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-progesterone therapy in perimenopausal women.
    Budoff PW; Sommers SC
    J Reprod Med; 1979 May; 22(5):241-7. PubMed ID: 222901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogens and endometrial hyperplasia.
    Thom MH; Studd JW
    Br J Hosp Med; 1980 May; 23(5):506, 508-9, 511-3. PubMed ID: 6992895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous postmenopausal estrogen-progesterone therapy].
    Affinito P; Tommaselli GA; Morgera R; Rinaldi M; Di Mauro P; Nappi C
    Minerva Ginecol; 1993 Mar; 45(3):77-85. PubMed ID: 8392669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens, progestogens and endometrial cancer.
    Gambrell RD
    J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of endometrial activity after radiation therapy for cervical carcinoma.
    Barnhill D; Heller P; Dames J; Hoskins W; Gallup D; Park R
    Obstet Gynecol; 1985 Dec; 66(6):805-8. PubMed ID: 2999661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate.
    Gordon J; Reagan JW; Finkle WD; Ziel HK
    N Engl J Med; 1977 Sep; 297(11):570-1. PubMed ID: 196195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
    Berger GS; Fowler WC
    J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hormone therapy on the endometrium.
    Deligdisch L
    Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial safety and bleeding with HRT: what's new?
    Sturdee DW
    Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial factors under treatment with oestrogen and oestrogen/progestogen combinations.
    Aylward M; Maddock J; Parker A; Protheroe DA; Ward A
    Postgrad Med J; 1978; 54 Suppl 2():74-81. PubMed ID: 740584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
    Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB
    Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in estrogen-treated patients with Turner syndrome.
    Demetriou E; Emans SJ; Crigler JF
    Obstet Gynecol; 1984 Oct; 64(4):459-64. PubMed ID: 6091005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.